About Haystack Oncology
Haystack Oncology is a company based in Baltimore (United States) founded in 2021 was acquired by Quest Diagnostics in April 2023.. Haystack Oncology has raised $67.02 million across 1 funding round from investors including ARE, Quest Diagnostics and Bruker. Haystack Oncology offers products and services including Haystack MRD. Haystack Oncology operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Baltimore, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Haystack Oncology, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$67.02 M (USD)
in 1 rounds
-
Latest Funding Round
$67.02 M (USD), Series A
Oct 17, 2022
-
Investors
ARE
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Quest Diagnostics
(Apr 27, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Haystack Oncology
Haystack Oncology offers a comprehensive portfolio of products and services, including Haystack MRD. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects ultralow ctDNA levels for residual disease monitoring in cancer patients.
Unlock access to complete
Unlock access to complete
Funding Insights of Haystack Oncology
Haystack Oncology has successfully raised a total of $67.02M through 1 strategic funding round. The most recent funding activity was a Series A round of $67.02 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $67.0M
-
First Round
First Round
(17 Oct 2022)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series A - Haystack Oncology | Valuation | Catalio Capital Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Haystack Oncology
Haystack Oncology has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Quest Diagnostics and Bruker. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to biomedical technology startups.
|
Founded Year | Domain | Location | |
|
Diversified research instrument systems are manufactured and supplied.
|
Founded Year | Domain | Location | |
|
Offers independent market intelligence for telecommunications, networking, and wireless markets.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Haystack Oncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Haystack Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Haystack Oncology Comparisons
Competitors of Haystack Oncology
Haystack Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Haystack Oncology
Frequently Asked Questions about Haystack Oncology
When was Haystack Oncology founded?
Haystack Oncology was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Where is Haystack Oncology located?
Haystack Oncology is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Who is the current CEO of Haystack Oncology?
Dan Edelstein is the current CEO of Haystack Oncology.
Is Haystack Oncology a funded company?
Haystack Oncology is a funded company, having raised a total of $67.02M across 1 funding round to date. The company's 1st funding round was a Series A of $67.02M, raised on Oct 17, 2022.
What does Haystack Oncology do?
Haystack Oncology was founded in 2021 and is based in Baltimore, United States. Operations focus on the oncology sector, where personalized diagnostic tests are developed using circulating tumor DNA detection technology. Minimal residual disease testing is optimized for recurrent or resistant cancers through tumor-informed liquid biopsies. These begin with tissue-based whole-exome sequencing to identify patient-specific mutations, supporting clinical decision-making in cancer care.
Who are the top competitors of Haystack Oncology?
Haystack Oncology's top competitors include Guardant Health, GRAIL and Foundation Medicine.
What products or services does Haystack Oncology offer?
Haystack Oncology offers Haystack MRD.
Who are Haystack Oncology's investors?
Haystack Oncology has 5 investors. Key investors include ARE, Quest Diagnostics, Bruker, Catalio Capital Management, and Exact Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.